CAR-T Therapy for Multiple Myeloma Is on the Horizon - Managed Healthcare Executive

Bispecific antibody therapies are also in development.

Multiple myeloma is a form of cancer characterized by the proliferation of plasma cells in the bone marrow. Although relatively rare, accounting for less than 2% of all cancer cases each year, multip… [+3902 chars]

full article...